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Mycobacterium tuberculosis (Mtb) is the causative agent of the infectious disease
tuberculosis (TB), which is a leading cause of death worldwide. Approximately one
fourth of the world’s population is infected with Mtb. A major unresolved question is
delineating the inducers of protective long-lasting immune response without inducing
overt, lung inflammation. Previous studies have shown that the presence of inducible
Bronchus-Associated Lymphoid Tissue (iBALT) correlate with protection from Mtb
infection. In this study, we hypothesized that specific Mtb factors could influence the
formation of iBALT, thus skewing the outcome of TB disease. We infected non-human
primates (NHPs) with a transposon mutant library of Mtb, and identified specific
Mtb mutants that were over-represented within iBALT-containing granulomas. A major
pathway reflected in these mutants wasMtb cell wall lipid transport and metabolism. We
mechanistically addressed the function of one such Mtb mutant lacking mycobacteria
membrane protein large 7 (MmpL7), which transports phthiocerol dimycocerosate (PDIM)
to the mycobacterial outer membrane (MOM). Accordingly, murine aerosol infection with
the Mtb mutant 1mmpl7 correlated with increased iBALT-containing granulomas. Our
studies showed that the 1mmpl7 mutant lacking PDIMs on the surface overexpressed
diacyl trehaloses (DATs) in the cell wall, which altered the cytokine/chemokine production
of epithelial and myeloid cells, thus leading to a dampened inflammatory response.
Thus, this study describes an Mtb specific factor that participates in the induction of
iBALT formation during TB by directly modulating cytokine and chemokine production in
host cells.
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INTRODUCTION
Mycobacterium tuberculosis (Mtb) is the causative agent of
pulmonary tuberculosis (TB). TB is caused by inhalation of
Mtb bacilli and it is currently estimated that approximately one
fourth of the world’s population is infected with Mtb (1). While
most individuals infected with Mtb are asymptomatic and do
not exhibit clinical symptoms, 5–10% of infected individuals can
progress to pulmonary clinical TB. The immune parameters that
distinguish latent TB from active pulmonary TB are not as yet
clearly defined.
The first interactions between Mtb and the host happen in
the lung airways immediately after inhalation of Mtb bacilli.
These early interactions involve alveolar macrophages (2) (AMs),
dendritic cells (3, 4) (DCs), and epithelial cells lining the
airway (5–7) and have the potential to drive immune responses.
As a result of initiation of immune responses, the tubercle
granuloma is formed, which is a hallmark immune structure
formed during TB (8). We have previously shown that protective
granulomas that are formed during latent TB are associated
with the formation of B-cell containing lymphoid follicles (9).
During severe active TB, granulomas that do not effectively
containMtb are comprised predominately of neutrophils (10, 11)
and permissive monocytes (12), which have been implicated in
general tissue destruction, thus skewing responses toward disease
progression. Non-protective granulomas are hallmarked by the
formation of hypoxic, necrotic cores that do not prevent Mtb
growth and eventually lead to dissemination to other organs
and tissues (10). The earliest mechanism(s) which determine the
nature and outcome of granulomas during infection remains
elusive, and are a focus of this work.
In this study, we aimed to determine the Mtb and host
specific factors that drive the formation of inducible bronchus
associated lymphoid tissue (iBALT) during TB. To examine the
Mtb specific factors involved, we utilized an Mtb transposon
mutant library to screen the induction of lymphoid follicles
using the Non-Human primate (NHP) model of pulmonary
TB. This screen allowed us to identify Mtb genes which
when mutated led to increased induction of iBALT within
granulomas. The NHP model exhibits characteristics associated
with human TB including the pulmonary cellular and acellular
lesions (13, 14). We found an over-representation of Mtb cell
wall mutants within iBALT containing granulomas and further
characterized the role of one such mutant using the mouse model
of TB. The mycobacteria membrane protein large 7 (Mmpl7)
inner membrane protein is best known for the transport of
phthiocerol dimycocerosate (PDIM) to the free fatty acid layer
of the mycobacterial outer membrane (MOM) (15, 16). The
role of lipid presentation in the MOM is well-documented
in modulating various host responses (17–19), suggesting that
MOM lipids contact with host cells in the lung plays a role in
disease progression. In light of these observations, we aimed to
understand how the Mtb 1mmpl7 cell wall mutant identified
in our screen modulates early epithelial signaling and myeloid
recruitment in order to coordinate granuloma structure and the
formation of iBALT. In this study we found that in the mouse
model, infection with the 1mmpl7 mutant drives decreased
bacterial burden and increased formation of iBALT, as was
observed in NHPs. Furthermore, the 1mmpl7 mutant also drove
decreased inflammatory cytokine and chemokine production in
vitro and in vivo, along with decreased accumulation of myeloid
and lymphoid immune cells. We demonstrate that the 1mmpl7
mutant overexpresses diacyl trehaloses (DATs), a Mtb cell wall
lipid, which can drive the observed decreased inflammatory
cytokines and chemokine production by in vitro macrophages
and also yields increased production of IL-10.
RESULTS
Identification of Mtb Genes Associated
With Formation of Protective Lymphoid
Follicles
TB granulomas contain distinct iBALT structures which are
protective in mice and macaques (9). NHPs infected with Mtb
exhibit the spectrum of disease severity observed clinically during
human TB, with a diverse array of granuloma structures reflected
by differences in immune cell recruitment and disease outcome
(14, 20). Thus, we used the NHP model to probe the early
host-Mtb interactions that mediate the signaling events that
initiate the induction of iBALT within TB granulomas. NHPs
were infected with 1 × 105 CFU of Mtb (H37Rv) mutants
from the himar1 transposon mutagenesis site hybridization
(TraSH) library (21, 22). Four-six weeks post-infection, the
animals were humanely euthanized due to TB disease. At
this time, macaque lungs demonstrated a wide distribution of
caseous and follicular granulomatous structures (Figure 1), with
follicular granulomas featuring prominent cellular structure.
In combination with mesodissection, DNA sequencing analysis
of separate B cell follicle containing granulomas, seeded by
Mtb mutants (23, 24), identified nine Mtb single mutants that
were highly represented within distinct iBALT containing TB
granulomas in macaques (Figure 1 and Table 1). Of the Mtb
mutants represented within these “protective” granulomas, two
members of the mycobacterial membrane protein large family
(Mmpl2 and Mmpl7), were well-reflected. MmpL2 is a putative
inner membrane transporter protein with unknown substrate,
while MmpL7 is an inner membrane protein associated with
phthiocerol dimycocerosate (PDIM) transport to the MOM (15,
16). The NAD dehydrogenase, NdhA is a non-essential protein
found in the inner mycobacterial membrane associated with
NADHmediated electron transfer to the electron transport chain
(25). EccD5 is an essential inner membrane protein that makes up
part of the type VII secretion system, the absence of which results
in sensitivity to detergents and killing by macrophage (26). ClpB
and Acr2 are both heat stress molecular chaperones regulated
by the alternative sigma factors SigH and SigE, respectively (27).
Of the two, only ClpB is essential for in vitro growth. The non-
redundant glutamine synthetases GlnA2 and GlnA4 are involved
in nitrogen metabolism but are not associated with any loss of
virulence in vivo (28). Cmtr is a cytosolic sensor of cadmium
Cd(II) and lead Pb(II) (29) which are trace metal contaminants
found in the lung (Table 1).
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FIGURE 1 | Identification of Mtb genes associated with formation of protective lymphoid follicles: Transposon site hybridization library (TraSH) using the himar1
transposon mutagenesis strategy was employed to create a Mtb mutant library for the specific discovery of Mtb genes influencing the progression of lymphoid follicle
containing granulomas in NHPs. NHPs were infected with 100,000 CFU of Mtb mutants and lung sections were harvested 4–6 weeks after infection. In combination
with mesodissection, the analysis of >1,200 separate lesions identified nine Mtb single mutants that were highly represented within protective iBALT containing TB
granulomas in macaques. Single Mtb mutants were isolated from single granulomas.
Taken together, the Mtb transposon screen conducted in
NHPs has identified a novel set of Mtb genes involved in
generation of lymphoid follciles within the lung, that appear to
controlMtbmetabolism and inner membrane lipid transport. In
this study, we chose to mainly focus on the interaction driven by
Mtb Mmpl7 that mediates formation of the granuloma.
1mmpl7 Mutant Drives Mtb Enhanced B
Cell Follicle Containing iBALT Formation in
Mouse Model
To determine the functional role of Mtb Mmpl7 in modulating
iBALT generation in vivo, we infected C57BL/6 mice (B6)
with 100 CFU Mtb Erdman or the 1mmpl7 mutant Erdman
strain and characterized immune recruitment and induction
of iBALT features in the lung. As previously shown, infection
with the 1mmpl7 mutant resulted in early decreased Mtb
CFU which recovered by 40 days post-infection (d.p.i.) in
the lung and spleen (Figure 2A). At a time when Mtb CFU
was comparable between the WT and mutant strains, we
observed that the total inflammation observed in the lungs of
the 1mmpl7 mutant infected mice was significantly decreased
(Figures 2B,C). However, despite significantly decreased overall
inflammation, infection with the 1mmpl7 mutant resulted
in increased formation of B cell lymphoid follicle containing
area, reflecting iBALT areas (Figures 2D–E). Furthermore, by
40 d.p.i., T cells were well able to infiltrate within iBALT
containing granulomas, as the area of T cell cuffing around the
granulomas was decreased in 1mmpl7 mutant infected mice
(Figures 2D,E). Together, these findings suggest thatMtb lacking
the Mmpl7 gene induces improved induction of iBALT and
decreased inflammation, suggesting thatMtb actively shuts down
iBALT formation utilizing virulence factors such as PDIM, or
alternatively, the reduced earlyMtb growth in theMmpl7 mutant
in vivo propagates iBALT containing granulomas.
It has been shown previously that the 1mmpl7 mutant lacks
the ability to transport PDIMs, an importantMtb structural lipid
and virulence factor, to the MOM, leading to an early growth
defect in vivo when mice are infected intravenously (15, 16).
Thus, to specifically address if the early decrease in Mtb CFU
burden in the mutant infection was responsible for increased
iBALT formation, we infected mice with a 5-fold higher dose
Frontiers in Immunology | www.frontiersin.org 3 June 2020 | Volume 11 | Article 1325
Dunlap et al. Mtb Factors Regulate iBALT Formation
TABLE 1 | Identification of Mtb genes associated with formation of protective
lymphoid follicles: Transposon site hybridization library (TraSH) using the himar1
transposon mutagenesis strategy was employed to create a Mtb mutant library for
the specific discovery of Mtb genes influencing the progression of lymphoid follicle
containing granulomas in NHPs.
Mtb genes identified Putative function
from NHP transposon screen
mmpL2 (Rv0507) 106 kDa Fatty acid transport
mmpL7 (Rv2942) 95 kDa Fatty acid transport
ndhA (Rv0392c) 50 kDa Electron transport
eccD5 (Rv1795) 53 kDa Type VII secretion (*)
clpB (Rv0384c) Molecular chaperone (*)
acr2 (Rv0251c) Molecular chaperone
glnA2 (Rv2222c) Glutamine biosynthesis
glnA4 (Rv2860c) Glutamine biosynthesis
cmtR (Rv1994c) Metal sensor, transcriptional regulator
NHPs were infected with 1 × 105 CFU of Mtb H37Rv mutants and lung sections were
harvested 4–6 weeks after infection. In combination with mesodissection, the analysis of
>1,200 lesions identified 9 Mtb mutants that were highly represented within protective
iBALT containing TB granulomas in macaques. *Essential gene.
(500 CFU) of Mtb 1mmpl7 to directly compare the ability
of 1mmpl7 mutant to induce iBALT when compared to low
dose (100 CFU) infection with wildtype (WT) Mtb Erdman
(Supplemental Figure 1). Using the higher dose model, our data
show that 1mmpl7 mutant still had early defects in Mtb CFU
in vivo in the lung and spleen as previously shown, but at 40
d.p.i. showed comparable CFU to WT Mtb and similar overall
inflammation (Supplemental Figures 1A,B). Importantly, the
higher dose model maintained the observed increased iBALT
formation (Supplemental Figure 1C). Whether this phenotype
was due partially or entirely to the lack of PDIMs on the MOM
or due to other changes in the 1mmpl7 mutant was further
evaluated in this study.
Furthermore, by 40 d.p.i., no differences in bacterial burden
were observed in the lung or spleen between WT Erdman
and 1mmpl7 mutant, which is more likely due to increased
control of WT Erdman while 1mmpl7 mutant CFU levels were
maintained. These findings demonstrate that our 5-fold higher
CFU dose aerosol infection used to compensate for the growth
defect in the 1mmpl7 mutant still recapitulates the in vivo
phenotype observed with low dose infection. These data suggest
that the observed phenotype of increased iBALT formation in the
1mmpl7 mutant infection is likely not an artifact of abrogated
Mtb growth.
1mmpl7 Mutant Mtb Limits Early Myeloid
Cell Accumulation in the Mtb-Infected
Lung
To examine the early immune events that occur in the lung
that mediate differences in iBALT formation, we infected mice
with 100 CFU wildtype Mtb Erdman or 5-fold higher CFU
(500 CFU) of the 1mmpl7 mutant and characterized myeloid
and T cell accumulation in the lung. Upon infection with the
1mmpl7 mutant, we observed decreased neutrophils, monocytes
and recruited macrophages at early time points as well as
decreased accumulation of alveolar macrophages (AMs) and
myeloid DCs (mDCs) when compared with accumulation inWT
Mtb infected lungs (Figures 3A,B). We saw similar decreases
in accumulation of total CD3+ T cells (Figure 3C), activated
and IFN-γ producing CD4+ (Figure 3D) and CD8+ T cells
(Figure 3E) at later time points.
These cellular changes coincided with early decreased
production of inflammatory cytokines, such as IL-6, G-CSF,
and IL-17, and chemokines, such as MIP-2 (CXCL2), and IP-
10 (CXCL10) that are associated with myeloid recruitment in
Mtb 1mmpl7 infected mice (Figures 3F–J). Interestingly, this
coincided with an early increased induction of IL-10 at 15
d.p.i., though this effect was abolished by the later timepoints
(Figure 3K). As IL-10 is a known mediator of anti-inflammatory
responses (30, 31), these findings suggest a potential mechanism
for the decrease in pro-inflammatory cytokines and lung
inflammation. Taken together, these data demonstrate an
overall “dampening” of the immune response during early
infection with the 1mmpl7 mutant, suggesting that decreased
inflammation and decreased neutrophilia may improve the
formation of protective iBALT containing granulomas, thus
imporving TB disease.
1mmpl7 Mutant Mtb Overexpresses DATs
and Limits Cytokine Production in Lung
Epithelial Cells
Having observed abrogated recruitment of myeloid cells after
infection with the Mtb 1mmpl7 mutant and decreased
cytokine/chemokine production in vivo (Figure 3), we
hypothesized that the 1mmpl7 mutant was specifically
modulating inflammatory molecule production and subsequent
recruitment of immune cells. Increased early IL-10 production
and decreased neutrophilia and inflammation observed after
infection with the 1mmpl7 mutant likely skewed the immune
response toward protective iBALT containing granulomas.
Alternatively, increased neutrophil accumulation and increased
pro-inflammatory cytokines, including G-CSF and IL-6, are
induced in response to WT Mtb infection and drive non-
protective, necrotic granulomas (10, 11, 32). To address if G-CSF
was a marker of active TB disease in humans, we measured
levels in individuals with active TB disease (ATB) or latent
Mtb infection (LTBI), in two human cohorts. We observed
that G-CSF production was increased in ATB individuals when
compared with LTBI or house contacts (HCs) (Figure 4A).
Furthermore, it was previously demonstrated that individuals
with ATB also have increased serum levels of IL-6 (33, 34). As
such, both G-CSF and IL-6 were used as cytokine indicators of
inflammatory response severity for the remainder of this study.
To further test this hypothesis in our model, we examined
mouse lung epithelial cells in vitro, which are a key source
of G-CSF, and other inflammatory cytokines in the context of
lung infection (5, 35–39). We assayed epithelial cell derived G-
CSF production in vitro after infection with either wildtype Mtb
Erdman or 1mmpl7 mutant. Firstly, we found that epithelial
cells infected with WT Mtb induced significant G-CSF in a
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FIGURE 2 | 1mmpl7 mutant drives Mtb enhanced B cell follicle formation in mouse model: Sex and age matched C57BL/6 mice were infected with 100 CFU of Mtb
Erdman WT or 1mmpl7. (A) Lung and spleen homogenates were used to determine Mtb CFU counts at indicated time points. (B,C) Lungs from Mtb-infected mice at
20 (top) and 40 (bottom) d.p.i. were formalin fixed, embedded in paraffin and used for H&E staining and inflammation was quantified by tracing areas. (D,E) B cell
follicles present within lung sections were visualized by confocal microscopy. Slides were visualized and quantified by outlining the lesions using the automated tool of
the Zeiss Axioplan 2 microscope. Infected groups (n ≥ 5) comparing WT Erdman and 1mmpl7 Mtb strains at individual time points were compared using Student’s
t-test. Mean and standard deviation (SD) were plotted for each group at each indicated time point. *p < 0.05, **p < 0.01, ***p < 0.001.
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FIGURE 3 | 1mmpl7 mutant Mtb limits myeloid cell accumulation in the lung: Sex and age matched C57BL/6 mice were infected with 100 CFU Mtb Erdman WT or
500 CFU 1mmpl7. Single cell suspensions were processed from infected lungs and immune cell subsets were analyzed by flow cytometry. (A) tissue resident myeloid
and (B) recruited myeloid cell accumulation in the Mtb-infected lungs was determined at indicated time points. (C) CD3+ lymphocytes, (D) CD4+ or (E) CD8+ T cells
were determined using flow cytometry. (F–K) Protein levels of inflammatory cytokine and chemokines IL-6, G-CSF, MIP-2(CXCL2), IL-17, IP-10 (CXCL10), and IL-10
were determined in lung homogenates at indicated time points. Infected groups (n = 5) comparing WT Erdman and 1mmpl7 Mtb strains at individual time points were
compared using Student’s t-test. Individual time points within the same group were compared using 2-way ANOVA with Bonferroni post-tests. Mean and standard
deviation (SD) were plotted for each group at each indicated time point. *p < 0.05, **p < 0.01, ***p < 0.001.
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FIGURE 4 | 1mmpl7 mutant Mtb overexpresses DATs and limits cytokine production in lung epithelial cells: (A) Serum samples from human active TB patients and
controls (Left) Panel: Mexico (TB- n = 30; ATB n = 13; LTB n = 33), Right Panel: South Africa (ATB n = 30; LTB n = 20) were analyzed for G-CSF levels. Mouse lung
epithelial cells (n ≥ 4 per group) were infected with Mtb Erdman WT or 1mmpl7 at (B) MOI = 1 or MOI = 5, respectively, for indicated time points. (C) Mouse lung
epithelial cells (n = 4) were infected with Mtb Erdman WT and/or 1mmpl7 at indicated ratios for a constant total MOI = 1. (D) Mouse lung epithelial cells (n = 4) were
infected with Mtb Erdman WT with or without the addition of heat-killed (HK) 1mmpl7. (A–D) Supernatants were collected and G-CSF concentration was quantified
by ELISA. (E) Total lipids from Mtb Erdman WT or 1mmpl7 were obtained from freshly grown bacteria (3 independent times) and extracted with chloroform:methanol
(2:1, v/v/) after normalization by total bacterial number. Total lipids (100 µg) were analyzed by TLC using as a solvent system (chloroform:methanol:water, 90:10:1,
v/v/v) and 10% sulfuric acid in ethanol as a developer to visualize total lipid contents (representative experiment shown). Densitometry analyses of the observed lipids
were performed using the NIH software ImageJ, n = 3 (where each value corresponds to independent extractions from freshly grown bacteria and TLCs). Human
cohort study groups were compared by 1-way ANOVA with Tukey’s post-test, or unpaired Student’s t-test, respectively. Infected groups comparing WT Erdman and
1mmpl7 Mtb strains under indicated conditions at individual time points were compared using 1-way ANOVA with Tukey’s post-test or unpaired Student’s t-test. TLC
densitometry was analyzed by unpaired Student’s t-test. *p < 0.05, **p < 0.01, ***p < 0.001.
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time-dependent manner. In contrast, infection of epithelial cells
with 1mmpl7 mutant resulted in significantly decreased G-
CSF production when compared to wildtype Erdman infection
(Figure 4B). When performing coinfection with varying ratios of
wildtype Erdman and 1mmpl7 mutant, we observed that even
3 times the presence of WT Mtb did not reverse the abrogated
G-CSF production observed upon 1mmpl7 mutant infection
(Figure 4C). Furthermore, we observed a significant decrease
in G-CSF production even when wildtype Erdman infected
epithelial cells were co-administered heat-killed (HK) 1mmpl7
mutant, suggesting that the inhibition of G-CSF was dependent
on a factor expressed by Mtb 1mmpl7 and did not depend on
FIGURE 5 | (A) DAT administration drives decreased inflammatory molecule production in epithelial and myeloid cells: Mouse lung epithelial cells (n = 5) were infected
with Mtb Erdman WT with or without the addition of raw DATs at MOI = 1 for 6 days. Mouse bone-marrow derived (B,C) macrophages (BMDMs) (n = 5) or (D,E)
dendritic cells (BMDCs) (n = 5) were infected with Mtb Erdman WT with or without the addition of DAT coated agarose beads, or 1mmpl7 for 3 days. Supernatants
were collected and the concentrations of cytokines G-CSF, IL-6, IL-1β, and IL-10 were quantified by multiplex assays. Multiple groups were compared by 1-way
ANOVA with Tukey’s post-tests. *p < 0.05, **p < 0.01, ***p < 0.001.
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the viability or infectivity of the bacteria (Figure 4D). These data
together suggest that a molecular factor present in the 1mmpl7
mutant is likely limiting G-CSF expression in vitro and in vivo.
From these data, we hypothesized that a lack of Mmpl7
in Mtb led to changes in the lipid profile of the MOM
beyond the reported loss of PDIMs (15, 16, 40), thus inducing
the presence of other lipids and virulence factors than those
present on wildtype Mtb Erdman (41). We hypothesized that
these lipids may decrease the production of G-CSF, IL-6 and
other inflammatory cytokines, thus driving decreased myeloid
recruitment and increased iBALT formation upon infection.
To test this, we freshly grew Mtb WT and 1mmpl7 mutant
bacteria three independent times, normalized by bacteria weight,
and extracted and characterized their total lipid content by
1 and 2 dimensional thin layer chromatography (1D or 2D
TLC) (Figure 4E and Supplemental Figure 2), using different
solvents systems allowing us to fully screen the wide range of
lipids present on the mycobacterial cell envelope. We found
that while sulpholipids (SLs), trehalose dimycolates (TDMs)
and trehalose monomycolates (TMMs) were present at similar
levels, diacyl trehaloses (DATs) were expressed at higher levels
in the cell envelope of the 1mmpl7 mutant Mtb (11.5% of
total lipid) when compared to WT Erdman (6.8% of total
lipid) (Figure 4E and Supplemental Figure 2, black arrows).
DATs are heterogeneous glycolipids (>30 molecular species
described) composed of a trehalose sugar structure with two
acyl chains, where the trehalose moiety is thought to bind to
the macrophage-inducible C-type lectin Mincle (42, 43). DATs
have been previously shown to negatively regulate the pro-
inflammatory response of the host, thus promotingMtb survival
(18, 19). Thus, these findings suggested that increased presence
of DATs in the 1mmpl7 mutant could be linked to the decreased
production of inflammatory molecules like G-CSF and IL-6 and
the dampened pulmonary inflammatory response observed in
vitro and in vivo (19).
DAT Administration Drives Decreased
Inflammatory Molecule Production in
Epithelial and Myeloid Cells
We next hypothesized that the increased expression of DATs
could abrogate production of cytokines, especially G-CSF, in
epithelial cells (5, 7), similar to what we observed with infection
with the 1mmpl7 mutant. To demonstrate this, we infected
lung epithelial cells with Mtb Erdman and co-treated them with
DATs. Our results show that co-treatment with DATs limited the
production of G-CSF and IL-6 by WT Mtb infected epithelial
cells (Figure 5A), similar to the responses observed when
1mmpl7 mutant single infection and coinfections were carried
out (Figure 4). Additionally, the inhibitory effect observed was
dose dependent, thus confirming that the overexpression of DATs
was one factor that was skewing the induction of cytokines upon
infection with the 1mmpl7 mutant. This effect was likely not
due to DAT-induced cell death, as levels of total live, apoptotic,
and dead cells were only slightly altered after addition of DATs
(Supplemental Figure 3A). IL-10 production within this culture
was below the limits of detection of the assay for all groups,
even with addition of DATs, thus suggesting that epithelial cells
are likely not a significant source of anti-inflammatory signals in
this phenomenon.
We next aimed to determine if this phenotype was specific to
epithelial cells or if the 1mmpl7 mutant also regulated cytokine
expression in myeloid phagocytes, and if the presence of DATs
modulated these responses as previously shown (19). Therefore,
we infected macrophages and DCs with WT and 1mmpl7
mutant (Figures 5B–E). We found that while 1mmpl7 mutant
abrogated IL-1β and IL-6 expression in both macrophages and
DCs (Figures 5C,E), the 1mmpl7 mutant surprisingly induced
increased IL-10 expression in both cell types when compared
to WT Mtb (Figures 5B,D). Furthermore, no differences in
cell death were observed between WT Mtb and the 1mmpl7
mutant (Supplemental Figures 3B,C), thus suggesting that this
finding is due to specific regulation of cytokine production,
not apoptosis induced abrogation. The decreased production
of IL-1β and IL-6 in phagocytes was likely not only due to
active inhibition by DAT alone, as co-treatment with DAT-
coated beads did not decrease production of these cytokines
during WT infection when compared to control beads. However,
in BMDMs the increased induction of IL-10 driven by the
1mmpl7 mutant Mtb over WT Erdman was recapitulated
by addition of DATs to WT Erdman infection (Figure 5B),
thus suggesting that DAT overexpression on 1mmpl7 mutant
Mtb actively induced expression of anti-inflammatory IL-10
produced by macrophages. The increased production of anti-
inflammatory IL-10 by lung macrophages may explain the early
increased IL-10 observed in vivo in lung homogenates. These
early anti-inflammatory signals may abrogate the production
of inflammatory cytokines and pulmonary neutrophilia, thus
skewing the immune response away from neutrophil rich,
non-protective granulomas, and toward iBALT containing,
protective granulomas.
DISCUSSION
Although pulmonary Mtb infection is the leading cause of death
by an infectious agent worldwide, the initial steps in pathogenesis
that govern the induction of iBALT formation within granulomas
remain unknown. In this study, using a transposon library in
the NHP pulmonary infection model, we have identified Mtb
drivers of B cell-containing iBALT formation. Our work here
demonstrates that murine infection with the 1mmpl7 mutant
induces increased iBALT formation by dampening early innate
immune responses. The 1mmpl7 mutant overexpressed DATs
in the cell wall, which drove abrogated inflammatory molecule
production and increased IL-10 in the lung, thus leading
to decreased cellular recruitment. This study provides novel
evidence for a critical role for Mtb specific factors in skewing
the earliest host pathogen interactions that drive protective or
detrimental disease outcomes.
Although significant advances have been made in
understanding the factors that aid in the intracellular survival
of Mtb and their potential as therapeutic targets using in vitro
approaches and the mouse model, it is unclear if these factors
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play important roles in human tubercle formation. Furthermore,
most physiological events cannot be modeled by targeting a
single gene or its substrates, as interaction and/or compensation
among several genes/pathways underpin complex outcomes.
Thus, in this study we have examined theMtb determinants that
mediate granulomas by using the well-established preclinical
model of NHP TB infection. The macaque model replicates
many facets of clinically observed Mtb infection, thus providing
relevance to identification of Mtb determinants that drive or
limit granuloma and iBALT formation. By infecting NHPs
with an Mtb mutant transposon library we have identified a
novel subset of Mtb genes associated with protective iBALT
containing granulomas that correspond with effective Mtb
control. Although the gene subsets identified using this approach
did not fall into any specific pathway, they were interrelated in
that they were predominantly involved in mycobacterial growth
and survival via responses to stress (Acr2, ClpB, Gln4, NdhA, and
Cmtr) or the synthesis/translocation of virulence components
including lipids & proteins (Mmpl2,Mmpl7, EccD5).
Among the two heat stress molecular chaperones identified
in our study ClpB has already been established as essential for
the in vitro growth of Mtb (27), however the importance of
Acr2 is yet to be established. Acr2 is the most up-regulated gene
following phagocytosis of Mtb by macrophages (27, 44) and is
under the control of the master regulator PhoP (45). Wilkinson
et al. found that Acr2 was strongly expressed in response to heat
shock protein (HSP) Rv0251c and appears to play a role in early
immune responses (46). HSPs assist in Mtb survival but also act
as signaling agents to the host inflammatory mechanisms. While
the role ofAcr2 inMtb virulence in humans is not clear, it remains
essential for virulence in a murine model of TB (46). To our
knowledge this is the first study to report on the association of
absence of Acr2 with protective granulomas in the NHP model.
Until recently NdhA was considered a non-essential protein
found in the inner mycobacterial membrane associated with
nicotinamide adenine dinucleotide (NADH) mediated electron
transfer to the electron transport chain (25). Recent studies by
Vilcheze et al. concluded that when NdhA is the only type I
NADH dehydrogenase present in Mtb it affects Mtb growth
and renders it susceptible to oxidative stress (47). Likewise,
while GlnA2 and GlnA4 are not associated with Mtb virulence
in vivo another member of this family GlnA1 was found to
contribute to Mtb virulence in a guinea pig model (48). Also,
while a direct role for Cmtr in Mtb virulence is yet to be
established, a transcriptional survey of intracellular mycobacteria
and their host macrophages revealed signatures of heavy metal
poisoning and an associated strong induction of Cmtr and Csor
which are known to encode metal responsive transcriptional
regulators (49).
The Mtb cell wall expresses a variety of virulence factors that
contribute to bacterial survival and intrinsic drug resistance.
Identification of genes that regulate uptake and secretion
machinery across the membrane is critical to characterizing the
corresponding secretory products and thus the pathogenesis
of Mtb. EccD5 has been identified as being associated with
protective granulomas. EccD5 as part of the ESX-5 system
is involved in the translocation of Proline-Proline Glutamate
(PPE) proteins and its disruption affects cell wall integrity
leading to strong attenuation of the pathogen in a mouse model
(26). But the impact of EccD5 in human Mtb infection or
in NHPs is not known. Lastly, we also identified Mmpl2 and
Mmpl7 to be associated with protective granulomas in the NHP
model. Sequencing of the Mtb genome revealed 12 membrane
proteins that were primarily involved in transport of Mtb lipids.
MmpL-mediated lipid secretion impacts both the innate ability
of the pathogen to survive intracellularly and also the host-
pathogen interactions that determine the disease outcome. It
has been previously established that only Mmpl4 and the well-
characterizedMmpl7, which transports PDIM to the MOM, have
both impaired growth kinetics and impaired lethality (50). In
summary, our Mtb mutant transposon library infection model
in the NHPs has identified for the first time several unique Mtb
genes whose roles in Mtb virulence were previously considered
as redundant.
SinceMmpl7 is the most well-characterized of allMmpl genes
being the known transporter of the virulence lipid PDIM, and as
the substrate forMmpl2 is currently not known (51), we decided
to focus our further studies utilizing the Mmpl7 mutant strain
(1mmpl7). Beyond reduced expression of PDIM, the 1mmpl7
mutant also has an established in vivo growth defect in the lung,
spleen, and liver of mice, which we compensated for in our
study by infecting with higher doses of the mutant compared to
wild type. The decreased CFU in the lungs of 1mmpl7 mutant
infected mice that we observed is similar to previous findings
by Cox et al. and others (52), but the decreased dissemination
to the spleen was not previously observed. This is likely due
to the use of different background Mtb strains and routes of
infection in our study. Furthermore, our higher dose aerosol
infection recapitulates a similar phenotype in increased iBALT
formation as the standard low dose aerosol infection. Thus, our
findings suggest that the improved TB disease outcomes observed
is likely not simply due to the absence of PDIMs or a growth
defect of the mutant, but that the observed increased iBALT
formation is likely driven specifically by the1mmpl7mutant and
overpression of DATs.
Despite using a higher dose of the 1mmpl7 mutant in
our infection studies, we observed enhanced iBALT formation
and abrogated inflammatory molecule production and cellular
recruitment, including both myeloid and lymphoid cell types.
As T cells are required for the formation of iBALT, it would
seem that slightly decreased T cell accumulation should also yield
decreased iBALT, which was not the case. However, our main
observed differences in cellular recruitment involved decreased
early neutrophil associated responses, specifically abrogated
cytokines like IL-6 and G-CSF, and increased IL-10. It is known
that neutrophils are overrepresented in non-protective, necrotic
granulomas that do not control or contain Mtb, and that
neutrophil counts in peripheral blood, as well as IL-6 levels,
correlate with ATB disease (10, 32, 33).
Our study confirms these findings with heightened blood
levels of G-CSF in people with active TB when compared to
LTBI, and as such we used these two inflammatory cytokines
as readouts for response severity for our in vitro experiments.
Thus, these data suggest that a lack of IL-6 and G-CSF and
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decreased neutrophils may be skewing toward a dampened
immune response, potentially mediated by increased early IL-
10, that allows for the enhanced formation of iBALT containing
granulomas as opposed to necrotic, neutrophil containing
lesions. This hypothesis is also supported by our findings in
vitro, which show decreased IL-6 and G-CSF in lung epithelial
cells, a key source of inflammatory molecules, after 1mmpl7
mutant infection.
Importantly, we observed increased IL-10 production in
macrophages and DCs after 1mmpl7 mutant infection. It
is known that IL-10 antagonizes IL-17 production, and thus
downstream G-CSF production (53), suggesting a potential
mechanism for our observed dampened immune responses
and improved outcomes. Indeed, Mtb is capable of dampening
immune responses mediated by pattern recognition receptors
(PRRs), and not just stimulating heightened inflammatory
responses by interactions with these receptors.
MmpL7 is colocalized with genes involved in polyketide
biosynthesis (pks genes) and genes involved in lipid metabolism
(PapA, FadD) suggesting that it is involved in complex lipid
transport involving more than one substrate in Mtb (54, 55).
Therefore, we aimed to determine if there were any other
differences in the lipid profile of Mtb beyond the loss of PDIM
that could explain the observed abrogated cytokine responses in
vivo and in vitro. We found that DATs are overrepresented in
the 1mmpl7 mutant, validated by both 1D and 2D thin layer
chromatography (TLC).MmpL10 is considered to be the putative
agent responsible for the transport of DAT across the plasma
membrane (51). Hence, it is likely that the absence of MmpL7
during infection could be compensated by MmpL10 function
accounting for the observed accumulation of DATs. The addition
of DATs during WT Mtb infection recapitulated our findings of
decreased inflammatory cytokine production in epithelial cells
and yielded increased IL-10 production by macrophages, both
supporting what was observed in 1mmpl7 mutant infection in
vivo. These findings suggest distinct mechanisms for driving
dampened immune responses depending on cell types, with
likely interactions of IL-10 sourced from macrophages driving
decreased production of inflammatory cytokines by epithelial
cells. DATs likely do not act in isolation, as addition of
DATs to WT Mtb Erdman infection did not fully recapitulate
all aspects of 1mmpl7 mutant infection in vitro in these
model systems.
Mycobacterial lipid virulence factors such as PDIMs are
known to mask pathogen associated molecular patterns (PAMPs)
and the resultant downstream PRR signaling (40). Lipid virulence
factors are also known to directly act as toll-like receptor (TLR)
antagonists (56). Apart from TLRs, other surface receptors
including Mincle, that recognizes trehalose moieties (42, 43),
are likely involved in this phenomenon as BMDMs from
Mincle deficient mice reportedly produce less G-CSF and TNF
in response to Mtb infection (57). Moreover, the expression
of TLRs is also known to vary between different phagocytic
cell types (58). Hence these separate responses are likely
due to differences in PRR expression and signaling by these
cell types. Interestingly, previous studies have shown DAT
dependent abrogation of inflammatory cytokine production in
monocytes and macrophages in vitro (19). This study was
performed using several different human phagocyte models
without abrogating the expression of Mincle. While Mincle
is established to interact with trehalose moieties, this study
validates our claim that DATs can drive abrogated inflammatory
cytokine production, independent of any manipulation of the
expression of Mincle, suggesting a separate mechanism. It is
likely that the interactions and modulated cytokine/chemokine
production we have observed involves other PRRs and Mtb
lipid factors, beyond the singular interaction between DATs and
Mincle (43).
While the various immune cells and cytokine/chemokine
signals that contribute to iBALT formation are well-established
in a variety of disease contexts (59), the Mtb specific factors that
drive these protective responses, and the mechanism of those
interactions, are poorly understood. This study demonstrates
that a single Mtb specific lipid factor can differentially affect
the ability of various cell types to produce inflammatory and
anti-inflammatory cytokines, all of which contribute in different
aspects to the milieu that fosters conditions beneficial to iBALT
formation. In the context of an immune structure as complex
as iBALT, where multiple coordinated and regulated signals and
cell types are required, future work will likely need to use a
similar approach across several in vivo and in vitromodel systems
examining multiple cell types in order to elucidate the concise
contribution of a specific Mtb factor and PRR interactions.
Future work may also need to examine not only multiple cell
types, but also locational and temporal cellular interactions
throughout the course of infection, as a singleMtb factor is likely
neither necessary nor sufficient in isolation to drive iBALT by
interactions with a single cell type at one specific time point.
While this study was not exhaustive in analyzing all potential
lipid factors involved, it provides a framework for determining
the contributions of the otherMtb genes and potential candidate
lipids in skewing toward protective outcomes. We acknowledge
that the role of any specific lipid in skewing iBALT formation
is not an isolated phenomenon, as Mtb mutants knocking
out certain lipids inevitably drive compensatory overexpression
of others. Furthermore, we expect that the increased iBALT
formation we have observed is likely due to a combination of a
lack of PDIM along with increased DATs, with the possibility of
other lipids being involved that we did not identify or assay for.
Our novel findings demonstrate that genes associated with
Mtb cell wall lipids are critical to the initial interactions between
Mtb and the host and suggest that Mtb specific lipids are key
determinants of the early immune response that skews toward
formation of iBALT. Our findings further provide a list of Mtb
gene candidates for future work examining conditions needed for
protective iBALT formation, specifically aimed at early responses
that determine these outcomes. We have also demonstrated for
the first time a panel of novel Mtb genes that are associated with
enhanced formation of protective iBALT containing granulomas
and improved disease outcomes, while most work on this topic
examines genes involved in detrimental host outcomes and loss
of protection. This study thus provides a framework for future
attenuated vaccine candidates and mechanistic studies across
model systems.
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MATERIALS AND METHODS
Non-human Primate Infection
AnMtb (H37Rv) transposon site hybridization mutants (TraSH)
library (kind gift of Dr. Chris Sassetti) was delivered high dose
(≥100,000) CFU via bronchoscopic procedure into the lungs
of triplicate Indian rhesus macaques. Delivery of bacteria to
the lower lungs was confirmed via dilution plating and Mtb
infection was confirmed by direct observation of the clinical
signs of TB and concurrent positive tuberculin skin test. NHPs
were humanely euthanized after being held 4–6 weeks due
to development of disease using prespecified criteria (60–62).
Lungs from infected animals were harvested and processed for
mesodissection as previously described (63, 64). Briefly, lung
sections were removed, formalin fixed and paraffin embedded.
A series of unstained and H&E slides were then made and used
with the mesodissection instrument and 2iD Imaging software.
The H&E guide slide is used to direct the consumable mill bit to
dissect the unstained slide and harvest the nuclear material for
downstream upscaling and identification. By staining of B cells,
iBALT associated lesions were first identified. The appropriate
sections from H&E slides were then dissected and used for
sequencing as previously described (65) to identify the singleMtb
mutant associated with each individual lesion (23, 24).
Mice
C57Bl/6 (B6) mice used were 6–8 weeks old and sex matched.
All treatments and conditions used to handle study animals are
in accordance with the approved Institutional Animal Care and
Use Committee (IACUC) guidelines atWashington University in
St. Louis.
Bacterial Strains, Infection and Instillation
Mtb (Erdman) and1mmpL7mutant (MJM39) (16) were stocked
in Proskauer-Beck with 0.05% tween 80 and stored at −80◦C.
Prior to infection, frozen stocks were thawed and placed in a
solution of sterile PBS for loading into the Glasscol nebulizer.
Mice were infected with aerosolized Mtb in the above Glasscol
nebulizer at tested doses of ∼100 CFU (low) or ∼500 CFU (5-
fold higher) ofMtb per mouse. At the indicated time points mice
were sacrificed via carbon dioxide narcosis and lungs and spleens
were harvested.
Microscopy and Inflammation, B Cell
Quantification
Lung pathology from formalin fixed paraffin embedded lungs was
assessed digitally using the automated tool of the Zeiss Axioplan
2 microscope (Carl Zeiss) of H&E stained slides to quantify
inflammation and immunofluorescence labeled slides B220, CD3
and counter stained with DAPI in order to assess lymphoid
follicle area.
Bacterial Culture and Cytokine Analysis
Bacterial burden was assessed using serial 10-fold dilutions
of lung or spleen and plated on 7H11 supplemented with
OADC (oleic acid, bovine albumin, dextrose, and catalase).
After 2–3 weeks incubation colonies were counted visually.
Cytokine/chemokine expression was analyzed in lung
homogenates from infected mice via Luminex (Millipore-Sigma)
or ELISA (R&D).
Flow Cytometry
Flow cytometry was conducted on single cell preparations
derived from infected and uninfected lungs using fluorochrome
conjugated antibodies:
Myeloid antigen presenting cell panel (66): CD11b (M1/70),
CD11c (HL3), Gr-1 (RB6-8C5), Siglec-F (E50-2440), Ly6G (1A8),
Ly6C (AL-21), CD64 (X54-5/7.1), MHC-II (M5/114.15.2). Cells
were defined as: AMs: CD11b−, CD11c+, Siglec-F+, CD64+.
mDCs: CD11b+CD11c+, MHC-II+. Neutrophils: CD11b+,
CD11c−, Gr-1hi. Monocytes: CD11b+ CD11c− Gr-1int and/or
Ly6C+. Recruited macrophages: CD11b+ CD11c−, Gr-1lo,
CD64+/−, Ly6C+/−, MHC-II+/−.
Activated lymphocyte panel (9, 67): CD3ε (500A2), CD4
(RM4-5), CB8α (53-6.7), CD44 (IM7), IFN-γ (XMG1.2).
Live, apoptotic, or dead cell panel (66): Annexin V (PE)
and 7-AAD (PerCP-Cy5.5) from the BD Pharmingen Apoptosis
Detection kit were utilized and cell percentages were quantified
by flow cytometry as per manufacturer’s suggested protocol
(BD Biosciences). The percentage of cells were defined as live
(Annexin V−, 7-AAD−), apoptotic (Annexin V+, 7-AAD−), and
dead (Annexin V+, 7-AAD+).
Data collection and analysis were conducted on the BD
LSR Fortessa, Fortessa-X20 Cytometers or the FACSJazz Cell
Sorter, all with FACS Diva software and post-acquisition analysis
conducted on FlowJo.
Human Serum Collection and Analysis
Human samples were collected on approval from the Ethics
Committee of the National Institute for Respiratory Diseases,
KwaZulu-Natal Research Institute for TB and HIV, Durban,
South Africa; and The American British Cowdray Medical
Center, Mexico City, Mexico on a protocol approved by the
Ethics Committee of the National Institute for Respiratory
Diseases (INER), KwaZulu-Natal Research Institute for TB
and HIV (Currently renamed AHRI), South Africa and The
American British Cowdray Medical Center. All subjects were
of similar socioeconomic status and unrelated to the third
generation as determined by a questionnaire. TB cases had
symptoms (weight loss >10 kg, cough, fever, night sweats for
>1 month, or cervical or axillary lymphadenopathy) and chest
radiographic findings consistent with recent pulmonary TB, a
positive sputum acid-fast smear and culture confirmed for Mtb.
Fresh blood samples from active pulmonary TB patients were
obtained from patients recruited to the Tuberculosis Outpatient
Clinic, INER, Mexico, or the KwaZulu-Natal Research Institute
for TB and HIV, South Africa. Serum samples from all patients
with active TB were collected prior to anti-Mtb treatment and did
not presented comorbidities such as diabetes, HIV, cancer, and
COPD. LTBI patients were defined as asymptomatic individuals
who had positive IGRA test results as previously described
(10). We simultaneously recruited a group of HCs and these
individuals were negative for IGRA tests at collection sites.
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In vitro Culture, Isolation, Stimulation, and
Infection
Mouse lung epithelial cell line C10 cells were cultured to
confluence in 24 well plates in DMEM. Prior to in vitro infection
hemocytometer counts from a representative well were used to
calculate multiplicity of infection (MOI). C10 cells were washed
once with sterile PBS and then infected withMtb orMtbmutant
at an MOI of 1 in DMEM without antibiotics and incubated at
37◦C, 7.5% CO2. Supernatants from the infection was collected
and stored at −80◦C. Cells were collected by tryspinization and
stained as per manufacturer’s protocol.
Primary B6 mouse bone marrow derived macrophages
(BMDMs) and dendritic cells (BMDC) were prepared as
previously described (66). Briefly, bone marrow was harvested
in a solution of serum free DMEM and then passed through a
70µm screen, spun down and then resuspended in red blood cell
lysis solution. Equal volume of cDMEM was added and again
spun down. The single cell suspension was plated at 1 × 106
cells per ml and supplemented with 4% GM-CSF for 7 days. At
harvest, adherent cells were collected as BMDMs, and floating
cells were collected as BMDCs, gently washed with CDMEM via
centrifugation (1,200 rpm, 6min at 4◦C), resuspended and then
plated at 1× 106 cells per ml.
Indicated cell types were stimulated with either DATs
resuspended in DMSO, or BSA- control or DAT-coated beads
suspended in PBS as indicated at 200µg/mL. Briefly, beads (1.5
× 109 Polybead polystyrene beads) were washed twice in 0.05M
carbonate-bicarbonate buffer (pH 9.6) and then incubated with
50 µg of DATs or buffer alone for 1 h at 37◦C. Beads were then
blocked with 5% BSA, washed repeatedly in 0.5% BSA, and finally
adjusted to 4.0× 108/ml in 0.5% BSA before being used (68).
Lipid Extraction and Analysis
Mtb bacterial pellets normalized by bacterial numbers
(counted by microscopy, 1 × 1010) were extracted with
chloroform:methanol (2:1, v/v) following the previously
published method (17). Dried total lipids extracts were analyzed
(loaded 100 µg by weight) by thin layer chromatography using
chloroform:methanol:water (90:10:1, v/v/v) as the mobile phase,
and 10% sulfuric acid in ethanol as a developer as described (68).
Densitometry using NIH ImageJ software was used to quantify
all the spots/lipids per lane in each TLC, and to calculate the
percentage of total DATs and total polyacyl trehaloses (PATs)
per lane. Densitometry analyses of each spot/lipids were also
calculated as using NIH ImageJ software (n = 3, where each
value corresponds to independent extractions and TLCs). DATs
were purified by preparative TLC as previously described for
other Mtb cell envelope lipids (68), and used for in vitro studies
at the indicated concentrations, resuspended in DMSO.
Statistical Analysis
Data analysis was conducted in GraphPad Prism 5 (La Jolla,
CA) using unpaired two tailed Student’s t-test for comparison
between two groups or one-way analysis of variance for multiple
comparisons. Significance is denoted as: ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001, not detected, ND.
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